3rd Meeting of the Strategic Advisory Group of Experts on IVDs

1 April – 31 July 2020

 

In March 2020, the group’s annual face-to-face meeting was cancelled due to the global pandemic of coronavirus disease (COVID-19). Instead, SAGE IVD established a remote process to update the EDL and provide WHO with IVD-related advice. Through successive rounds of remote voting and online deliberations from April to July 2020, and two extraordinary sessions in October and November, SAGE IVD managed to consider and make recommendations on every application made to update the EDL, including late-breaker submissions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests, as well as to share progress updates and discuss strategic topics.

 

2020 Strategic Advisory Group of Experts on IVDs

  1. Dr Rashad Abdul-Ghani
  2. Sara Alqabandi
  3. Ghaya Abdellatif Alwahdanee
  4. Anurag Bhargava
  5. Dr Catharina Boehme
  6. Dr Jean Pierre Chanoine
  7. Dr Gvantsa Chanturia
  8. Dr Wenxiang Chen
  9. Chansy Dalavong
  10. Alice Emeka
  11. Dr Ronnie Gavilán Chávez
  12. Dr Ravnit Grewal
  13. Dr Isao Hamaguchi
  14. Michelle McNiven
  15. Dr Nwe Oo
  16. Dr Shahin Sayed
  17. Dr Lee Schroeder
  18. Valerie Wilson
  19. Sangay Zangmo

 

Applications for new product categories

  1. Aspergillus antigen test
  2. Aspergillus IgG
  3. Pneumocystis PCR
  4. Point-of-care Sickle cell test
  5. Trypanosoma cruzi IgG
  6. Prolactin
  7. Cortisol
  8. Serum protein electrophoresis for Primary Immune deficiency
  9. Serum and urine protein electrophoresis for myeloma
  10. CSF profile
  11. Rubella IgG
  12. Rubella IgM
  13. Measles IgM
  14. Measles IgG
  15. Measles PCR
  16. Leishmania Direct agglutination test
  17. Luteinizing hormone
  18. Follicle Stimulating Hormone
  19. Estrogen
  20. Progesterone
  21. Erythrocyte sedimentation rate
  22. S.pyogenes rapid test
  23. S.pyogenes PCR in throat swab
  24. Epidermal Growth Factor Receptor PCR

 

Suggested edits to previous EDL entries

 

Additional evidence for the conditional listing

1. Kato Katz
2. Immunoglobulin levels
3. Lymphocyte subtype enumeration
4. Zika IgM
5. Histoplasma antigen

Submission for negative listing

1. HIV Western Blot
2. MTB Commercial serological tests

Public Comments

No submissions

Full submissions will be available soon, they are being migrated to the new WHO web platform. In the meantime submissions are available upon request at edlsecretariat@who.int


Disclaimer

WHO publishes the full submissions as received from the submitters. The submissions may include references to specific companies or certain manufacturers’ products and/or contain package inserts. This does not mean in any way that they are endorsed or recommended by WHO in preference to others of a similar nature or that WHO provides any representation or warranty of any kind in relation thereof. WHO disclaims any and all liability whatsoever that may arise as a result of, or in connection with, the procurement, distribution and use of any product referred to in the submissions.